Netherlands (NL)

Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome (2026) Moser LM, Hutter M, Ahlmann M, Alonso-Saladrigues A, Attarbaschi A, Ayuk FA, Baldus CD, et al. Journal article Quantum Key Distribution over Free Space Optical Satellite Links in the 6G Era (2026) Papanikolaou VK, Dowhuszko AA, Galambos M, Guerra-Yanez C, Salgado HM, Djordjevic GT, Kleinpab P, Doelman N Conference contribution CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial (2026) Albach FN, Rehm MC, Hütter-Krönke ML, Le TH, Giezen JM, Torgutalp M, Sattler A, et al. Journal article Protein landscape of the chromatin domains in the malaria parasite Plasmodium falciparum (2026) Ramón-Zamorano G, Mainye S, Kimmel J, de Krijger I, Kanyal A, Horáčková V, Gockel J, et al. Journal article USP8 controls proteostasis pathways in B cells and multiple myeloma (2026) Dufner A, Thery F, Monaco G, Lazarevic J, Gorka O, Chevalier N, Campos Alonso M, et al. Journal article Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA study (2026) Taylor PC, Schett G, Huizinga TW, Ibrahim F, Zhou B, Huang S, Gambale J, et al. Journal article An individual participant data meta-analysis of predictors of adherence to internet-based interventions for depression (2026) Tong L, Panagiotopoulou OM, Miguel C, Harrer M, Amarnath A, Ciharova M, Gemmill AW, et al. Journal article Further characterization of the BRSK2-associated neurodevelopmental disorder (2026) Singhal P, Hsieh TC, Ehmke N, Bacchelli E, Viggiano M, Maestrini E, Visconti P, et al. Journal article Electromagnetic Tracking (2026) Bert C, Kolkman-Deurloo IK, Beaulieu L Authored book Fumarate hydratase-deficient renal cell carcinoma – results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment (2026) Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, et al. Journal article